Oasmia Pharmaceutical AB

About Company

Oasmia is developing a new generation of drugs with emphasis on human and veterinary oncology. Our main business activity focuses on improving product life cycles and the versatility of current pharmaceuticals. In-house research in nanotechnology and a long-term working basis can be seen as a guarantee for reaching our highly set goals.

In addition to strategic investments in oncology we also have a number of promising patents and candidates in therapy fields such as infection, asthma and neurology.